The progress of Arizona’s bioscience sector is chronicled annually, including key developments and data on jobs, wages, research funding, risk capital, and more.
Arizona’s bioscience sector is performing at historically high levels two decades after the creation of Arizona’s Bioscience Roadmap placed the state on a long-term trajectory toward success. For a closer look at the data and to learn more about the past year’s developments and accomplishments, dive into the Latest Progress of the Biosciences in Arizona.
2020 Progress ReportView/Download
The COVID-19 pandemic brought unspeakable suffering to Arizona, and revealed serious challenges in the state’s health-care system, especially for communities of high social vulnerability. But the crisis also brought forth the best from the state’s responsive bioscience sector, as researchers, companies, and health-care leaders made significant contributions to help us navigate 2020.
2019 Progress ReportView/Download
For the biosciences in Arizona, 2019 was almost entirely good news. The state’s research enterprise performed better than ever, with all-time highs for National Institutes of Health funding and university R&D. Tech transfer was looking up. Risk capital set a record. And bioscience jobs and wages continued to grow faster than the private sector as a whole. But as 2020 began, a global crisis loomed.
2018 Progress ReportView/Download
This 8-page brochure illustrates the importance of the robust bioscience ecosystem here in Arizona and how Arizona’s Bioscience Roadmap Steering Committee is advancing and accelerating this critical ecosystem. The brochure also highlights the advances made in the state’s bioscience sector during 2018 in areas such as entrepreneurism, venture capital, industry, research, education, and clinical care.
2017 Progress ReportView/Download
Arizona’s bioscience sector is adding jobs at a rate outpacing the biosciences nationally and the state’s overall private sector, while the state’s public universities are seeing increases in bioscience research funding, expenditures and tech transfer, according to the new data. However, there was a decline in bioscience venture capital over the past two years.
2016 Progress ReportView/Download
The year 2016 was highlighted by a $43 million precision-medicine research grant for University of Arizona, TGen’s affiliation with City of Hope and planned Phoenix expansion, the announcement of the Mayo Clinic School of Medicine in partnership with Arizona State University, and the unveiling of plans for a new biotech campus along Tempe Town Lake.
2015 Progress ReportView/Download
The state’s bioscience industry continues its strong job and wage growth and had its best venture capital year since 2011, according to the new data. While bio-related university startups continued to increase, there were declines in research dollars and expenditures.
2014 Progress ReportView/Download
The year 2014 was highlighted by the merger of Banner Health with the University of Arizona Health Network, construction on the Phoenix Biomedical Campus, progress in planning the Arizona Bioscience Corridor in northeast Phoenix, and the launch of the updated Arizona’s Bioscience Roadmap.
Earlier reports are available on the First Decade page.